Authors:
CASTRO JL
BROUGHTON HB
RUSSELL MGN
RATHBONE D
WATT AP
BALL RG
CHAPMAN KL
PATEL S
SMITH AJ
MARSHALL GR
MATASSA VG
Citation: Jl. Castro et al., 5-(PIPERIDIN-2-YL)-1,4-BENZODIAZEPINES AND 5-(HOMOPIPERIDIN-2-YL)-1,4-BENZODIAZEPINES - HIGH-AFFINITY, BASIC LIGANDS FOR THE CHOLECYSTOKININ-B RECEPTOR, Journal of medicinal chemistry, 40(16), 1997, pp. 2491-2501
Authors:
ROWLEY M
COLLINS I
BROUGHTON HB
DAVEY WB
BAKER R
EMMS F
MARWOOD R
PATEL S
PATEL S
RAGAN CI
FREEDMAN SB
BALL R
LEESON PD
Citation: M. Rowley et al., 4-HETEROCYCLYLPIPERIDINES AS SELECTIVE HIGH-AFFINITY LIGANDS AT THE HUMAN DOPAMINE D4 RECEPTOR, Journal of medicinal chemistry, 40(15), 1997, pp. 2374-2385
Authors:
STERNFELD F
BAKER R
BROUGHTON HB
GUIBLIN AR
JELLEY RA
MATASSA VG
REEVE AJ
BEER MS
STANTON JA
HARGREAVES RJ
SHEPHEARD SL
LONGMORE J
RAZZAQUE Z
GRAHAM MI
SOHAL B
STREET LJ
Citation: F. Sternfeld et al., THE CHEMICAL EVOLUTION OF 2-[5-(1,2,4-TRIAZOL-4-YL)-1H-INDOL-3-YL]ETHYLAMINE (L-741,604) AND ANALOGS - POTENT AND SELECTIVE AGONISTS FOR 5-HT1D RECEPTORS, Bioorganic & medicinal chemistry letters, 6(15), 1996, pp. 1825-1830
Authors:
CASTRO JL
BALL RG
BROUGHTON HB
RUSSELL MGN
RATHBONE D
WATT AP
BAKER R
CHAPMAN KL
FLETCHER AE
PATEL S
SMITH AJ
MARSHALL GR
RYECROFT W
MATASSA VG
Citation: Jl. Castro et al., CONTROLLED MODIFICATION OF ACIDITY IN CHOLECYSTOKININ B RECEPTOR ANTAGONISTS - ZEPIN-3-YL)-N'-[3-(TETRAZOL-5-YLAMINO)PHENYL]UREAS, Journal of medicinal chemistry, 39(4), 1996, pp. 842-849
Authors:
KULAGOWSKI JJ
BROUGHTON HB
CURTIS NR
MAWER IM
RIDGILL MP
BAKER R
EMMS F
FREEDMAN SB
MARWOOD R
PATEL S
PATEL S
RAGAN CI
LEESON PD
Citation: Jj. Kulagowski et al., L)PIPERAZIN-1-YL]METHYL]-1H-PYRROLO[2,3-B]PYRIDINE - AN ANTAGONIST WITH HIGH-AFFINITY AND SELECTIVITY FOR THE HUMAN DOPAMINE D-4 RECEPTOR, Journal of medicinal chemistry, 39(10), 1996, pp. 1941-1942
Authors:
ROWLEY M
BROUGHTON HB
COLLINS I
BAKER R
EMMS F
MARWOOD R
PATEL S
PATEL S
RAGAN CI
FREEDMAN SB
LEESON PD
Citation: M. Rowley et al., ETHYL-3-(1-(2-PHENYLETHYL)PIPERIDIN-4-YL)ISOXAZOLE - A POTENT, SELECTIVE ANTAGONIST AT HUMAN CLONED DOPAMINE D4 RECEPTORS, Journal of medicinal chemistry, 39(10), 1996, pp. 1943-1945
Citation: Hb. Broughton et al., STUDIES OF IMIDAZOLE AND PYRAZOLE PROTONATION USING ELECTROSTATICALLYTRAINED NEURAL NETWORKS, Perkin transactions. 2, (3), 1995, pp. 431-435
Citation: Jr. Atack et al., INOSITOL MONOPHOSPHATASE - A PUTATIVE TARGET FOR LI+ IN THE TREATMENTOF BIPOLAR DISORDER, Trends in neurosciences, 18(8), 1995, pp. 343-349
Authors:
RUSSELL MGN
CASTRO JL
MATASSA VG
BEER MS
HEALD A
SCHOLEY K
STANTON JA
BROUGHTON HB
Citation: Mgn. Russell et al., SYNTHESIS AND SEROTONERGIC ACTIVITY OF BENZOFURAN AND DIHYDROBENZOFURAN ANALOGS OF 5-CARBOXAMIDOTRYPTAMINE, Bioorganic & medicinal chemistry letters, 4(10), 1994, pp. 1207-1212
Authors:
POLLACK SJ
ATACK JR
KNOWLES MR
MCALLISTER G
RAGAN CI
BAKER R
FLETCHER SR
IVERSEN LL
BROUGHTON HB
Citation: Sj. Pollack et al., MECHANISM OF INOSITOL MONOPHOSPHATASE, THE PUTATIVE TARGET OF LITHIUM-THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 91(13), 1994, pp. 5766-5770
Authors:
MCDONALD IM
BODKIN MJ
BROUGHTON HB
DUNSTONE DJ
KALINDJIAN SB
LOW CMR
Citation: Im. Mcdonald et al., 2-NAP - A SELECTIVE, HYDROPHILIC, NONPEPTIDE CCKA-RECEPTOR ANTAGONISTDERIVED FROM THE CHOLECYSTOKININ C-TERMINAL DIPEPTIDE, Bioorganic & medicinal chemistry letters, 3(8), 1993, pp. 1511-1516
Authors:
POLLACK SJ
KNOWLES MR
ATACK JR
BROUGHTON HB
RAGAN CI
OSBORNE SA
MCALLISTER G
Citation: Sj. Pollack et al., PROBING THE ROLE OF METAL-IONS IN THE MECHANISM OF INOSITOL MONOPHOSPHATASE BY SITE-DIRECTED MUTAGENESIS, European journal of biochemistry, 217(1), 1993, pp. 281-287